ESC Professional Premium Access

Coronary artery disease - Epidemiology, prognosis, outcome 5

Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session type: Moderated ePosters
Date: 28 August 2022
Time: 10:15 - 11:00

Congress Session

7 presentations in this session

Remnant cholesterol contributes to residual lipid risk after acute coronary syndromes

Speaker: Doctor F. Wenzl (Zurich, CH)
Thumbnail

Prevalence of coronary atherosclerosis in individuals with pre-diabetes and diabetes compared to normoglycemic individuals

Speaker: Professor C. Ostgren (Linkoping, SE)
Thumbnail

Low-density lipoprotein cholesterol levels and long-term bleeding in patients undergoing percutaneous coronary intervention: 5-year outcomes from a large cohort study

Speaker: Doctor J. Li (Beijing, CN)
Thumbnail

Heme oxygenase-1 polymorphisms associate with ischemic cardiac complications and mortality in type 1 diabetes

Speaker: Doctor H. Segersvard (Helsinki, FI)
Thumbnail

Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and impaired glucose metabolism

Speaker: Doctor D. Sa (Funchal, PT)
Thumbnail

Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals of the general population with and without diabetes mellitus

Speaker: Doctor P. Haller (Hamburg, DE)
Thumbnail

Circulating miRNAs as independent predictors of cardiovascular mortality in patients with type 2 diabetes mellitus

Speaker: Mrs C. Eyileten (Warsaw, PL)
Thumbnail

7 speakers from this session

Doctor Florian Alexander Wenzl

University of Zurich, Zurich (Switzerland)
0 follower

Professor Carl Ostgren

Linkoping University, Linkoping (Sweden)
0 follower

Doctor Jiawen Li

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)
1 presentation
0 follower

Doctor Heli Segersvard

Minerva Foundation Institute for Medical Research, Helsinki (Finland)
0 follower

Doctor Debora Sa

Hospital Dr. Nelio Mendonca, Funchal (Portugal)
0 follower

Doctor Paul Michael Haller

The University Heart and Vascular Center Hamburg, Hamburg (Germany)
0 follower

Mrs Ceren Eyileten

Medical University of Warsaw, Warsaw (Poland)
1 follower

This platform is supported by

logo Novo Nordisk